Sunday, June 11, 2023 8:42:23 PM
Hi Meirluc:
Thank you for your calm and light-hearted approach.
I agree, it seems likely that if #murcidencel works for GBM, it should work for other types of solid tumors, as well.
The point I was trying to make has to do with the quality of evidence upon which to base an opinion or make a financial investment.
I'm trying to say that evidence that has been vetted by objective third parties and published in peer-reviewed journals deserves more credibility than evidence that is presented by a company employee whose information that hasn't been vetted by anyone else, especially when the employee works for a company that has a huge amount to gain, is heavily invested in the outcome.
But that's just my opinion/perspective.
I'm glad you feel optimistic, and maybe there are many others like you out there. Perhaps that's why the share price has been rising lately. The recent rise has certainly been a welcome development from my perspective.
Best wishes to you,
-- OJ
Thank you for your calm and light-hearted approach.
I agree, it seems likely that if #murcidencel works for GBM, it should work for other types of solid tumors, as well.
The point I was trying to make has to do with the quality of evidence upon which to base an opinion or make a financial investment.
I'm trying to say that evidence that has been vetted by objective third parties and published in peer-reviewed journals deserves more credibility than evidence that is presented by a company employee whose information that hasn't been vetted by anyone else, especially when the employee works for a company that has a huge amount to gain, is heavily invested in the outcome.
But that's just my opinion/perspective.
I'm glad you feel optimistic, and maybe there are many others like you out there. Perhaps that's why the share price has been rising lately. The recent rise has certainly been a welcome development from my perspective.
Best wishes to you,
-- OJ
Recent NWBO News
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
